Substantial progress has been made in coronary magnetic resonance angiography (CMRA) since the first reports of visualizing the ostia of coronary arteries in the late 1980s (1, 2) . A prospective multicenter study shows that 3-dimensional CMRA using a spoiled gradient-echo sequence allows for accurate detection of coronary artery disease (CAD) in the proximal and middle segments of coronary arteries at 1.5-T (3). Steady-state free precession (SSFP) imaging (4) was later shown to offer superior signal-to-noise ratio (SNR) and blood-myocardium contrast in CMRA. In recent years, improved gradient performance and radiofrequency (RF) receiving coils and advanced data acquisition techniques, including navigator gating and parallel imaging (5, 6) , allowed whole-heart CMRA within 10 to 15 min (7) . A recent study of 131 patients using the SSFP whole-heart CMRA approach at 1.5-T demonstrates moderate sensitivity and high specificity for noninvasive detection of significant narrowing in coronary arterial segments of Ն2 mm in diameter (8, 9) . However, a comparative study is required to verify whether SSFP improves the diagnostic accuracy over the conventional gradient-echo sequence.
Despite the substantial progress in imaging hardware and techniques, to date the clinical utilization of CMRA remains limited for the detection of CAD. Relatively low spatial resolution and long imaging time are the 2 major factors. Now, 3.0-T has been shown to be a promising platform for performing CMRA (10) . The theoretical doubling of SNR from 1.5-to 3.0-T can be traded for improved spatial resolution and/or reduced imaging time. Nevertheless, the SSFP imaging technique that has gained wide acceptance at 1.5-T is prone to imaging artifacts at 3.0-T because of the increased magnetic field inhomogeneity and RF distortion at higher field strengths. In addition, energy deposition is increased by a factor of 4 from 1.5-to 3.0-T.
A recent study has demonstrated the feasibility of wholeheart CMRA at 3.0-T with slow infusion of a high relaxivity clinical contrast media Gd-BOPTA (11), using a spoiled gradientecho technique. Spoiled gradientecho imaging is less sensitive to static and RF field inhomogeneities, and reduces RF power deposition and repetition time (TR) as compared with SSFP imaging. Contrast-enhanced data acquisition improves SNR and contrast-to-noise ratio (CNR). The purpose of this study was to prospectively evaluate the diagnostic performance of this 3.0-T whole-heart CMRA technique on patients with suspected CAD.
Methods

Study population.
From April 2007 to July 2008, a total of 96 consecutive patients scheduled for conventional coronary angiography were prospectively recruited in this study. Exclusion criteria were general contraindications to MR examination (claustrophobia, pacemaker), unstable angina, atrial fibrillation, patients with coronary stents or bypass grafts, and renal insufficiency (estimated glomerular filtration rate assessed by creatinine clearance Ͻ60 ml/min/1.73 m 2 ). Twenty-seven patients were excluded for these reasons, and 69 patients (36 men; age 61 Ϯ 10 years) underwent whole-heart CMRA before conventional coronary angiography (Fig. 1) . The average interval between CMRA and cardiac catheterization was 2 days, ranging from 0 to 12 days. No clinical cardiac events were reported between the examinations. The study protocol was approved by the Institutional Review Board. Written informed consent was obtained from each patient. Patient preparation. A beta-blocker (metoprolol tartrate, 25 to 50 mg) was given orally to patients with heart rate Ͼ75 beats/min before CMRA. No nitroglycerin was given to the patients before the test. Contrast-enhanced whole-heart CMRA. The CMRA was performed on a 3.0-T whole-body scanner (MAGNE-TOM Trio, A Tim System, Siemens AG Healthcare, Erlangen, Germany) with maximum slew rate of 200 mT/m/ms and a maximum gradient strength of 40 mT/m. A 12-element matrix coil (6 anterior and 6 posterior elements) was activated for data collection. Patients were trained to perform regular, shallow breathing and to avoid changes in depth of breathing during the data acquisition. The R-wave acquired from a 3-lead wireless vectorcardiogram was used to trigger the data acquisition. All images were collected under free breathing with the patient in supine position. The procedures were as follows: 2-dimensional scout images were first obtained in 3 orthogonal orientations to identify the position of the heart and diaphragm. To determine the optimal data acquisition window, retrospective electrocardiography (ECG)-triggered cine images (50 cardiac phases reconstructed) were acquired in a 4-chamber view using a fast low-angle shot (FLASH) sequence during free breathing. The global cardiac motion was visually assessed from cine images to determine the patient-specific trigger-delay time and duration of data acquisition window per heartbeat. For whole-heart CMRA, 0.2 mmol/kg body weight of Gadobenate dimeglumine (MultiHance, Bracco Imaging SpA, Milan, Italy) was slowly infused using a power injector (Spectris, Medrad, Indianola, Pennsylvania) at a rate of 0.3 ml/s, immediately followed by 20 ml saline at the same rate. Sixty seconds after the initiation of contrast administration, whole-heart CMRA data acquisition was started. The imaging volume was prescribed in the axial plane to cover the entire heart. A navigator-gated, ECGtriggered, fat-saturated, inversion-recovery prepared segmented 3-dimensional FLASH sequence was employed (11) . Prospective real-time adaptive motion correction was applied in the superior-inferior direction to compensate for the respiratory motion with a correction factor of 0.6 (12) . Imaging parameters included the following: TR/TE (echo time) ϭ 3.0/1.4 ms, flip angle ϭ 20°, readout bandwidth ϭ 610 Hz/pixel, acquired voxel size ϭ 1.3 ϫ 1.3 ϫ 1.3 mm 3 and interpolated to 0.65 ϫ 0.65 ϫ 0.65 mm 3 . Data acquisition was accelerated by employing generalized autocalibrating partially parallel acquisitions in the phaseencoding direction with a factor of 2. A nonselective inversion pulse was applied before the navigator-gating and data acquisition to suppress background tissues. The inversion-recovery time was 200 ms. Conventional coronary angiography. X-ray coronary angiography was performed in all patients and evaluated by quantitative coronary angiography (QCA [QuantCor QCA, Siemens AG Healthcare]) by 2 cardiologists in consensus who were blinded to the CMRA results. The standard 15-segment American Heart Association classification system was used. All coronary artery stenoses were graded in at least 2 orthogonal views, and the measurement was performed in the projection that showed the highest degree of stenoses. Stenoses were quantitatively evaluated for segments with a reference diameter of 1.5 mm or more. Segments distal to complete occlusions were excluded for analysis. Significant CAD was defined as a luminal diameter reduction of Ն50% in coronary arteries. CMRA image analysis. All CMRA images were transferred to an external workstation (MMWP, Siemens AG Healthcare), and patient information was removed. All CMRA images were independently assessed by 2 experienced readers who were blinded to the patient information. Axial source images, curved multiplanar reformations, and thin-slab maximum intensity projection images were assessed on a per-segment basis. CoronaViz software (Siemens Corporate Research, Princeton, New Jersey) were used for CMRA images to project multiple vessels onto a single image. The MR image quality was graded on a 4-point scale: 1 ϭ nonassessable with severe image artifacts, poor vessel contrast; 2 ϭ assessable with moderate image artifacts, fair vessel contrast; 3 ϭ assessable with minor artifacts, good vessel contrast; and 4 ϭ assessable with no apparent artifacts, excellent vessel contrast) (3). The severity of luminal diameter reduction as being Ͻ50% or Ն50% was visually assessed by 2 readers independently. The disagreement of diagnosis between the 2 readers was settled by a consensus reading. Statistical analysis. All statistical analysis was performed using statistical software (version 9.1, SAS Institute Inc., Cary, North Carolina). Quantitative variables were expressed as mean value Ϯ SD, and categorical variables as percentages. The diagnostic performance of CMRA for the detection of significant coronary artery stenosis (sensitivity, specificity, positive predictive value, negative predictive value, and accuracy with 95% confidence intervals) were calculated on a per-segment, -vessel, and -patient basis using invasive X-ray coronary angiography as the reference standard. In the primary analysis, only the assessable segments were included; and the calculations were performed on per-patient, -vessel, and -segment basis. In the second analysis, the intention-to-diagnose approach (13) was used, and nonassessable segments were considered to have a stenosis (14) . Interobserver agreement was assessed on a segmental basis for the image quality grading and stenosis analysis by using a weighted and unweighted kappa, respectively.
Results
The characteristics of the study population are summarized in Table 1 . The CMRA was successfully completed in 62 of 69 (90%) patients. Seven patient studies were aborted owing to poor ECG signal (n ϭ 3), or extremely low respiratory gating efficiency (navigator efficiency Ͻ20% by the time half of the imaging data were collected; n ϭ 4). Acquisition time of whole-heart CMRA was 9.0 Ϯ1.9 min. Mean heart rate during CMRA was 67 Ϯ 7 beats/min. The CMRA was acquired during diastole in 53 patients (acquisition window 135 Ϯ 33 ms) and during systole in 9 patients (acquisition window 89 Ϯ 8 ms). The trigger-delay time was 554 Ϯ 143 ms. The average navigator efficiency was 35%. The average duration of contrast injection was 1.5 min. Twenty (29%) patients received an oral beta-blocker before CMRA. Figure  2 shows representative CMRA images from a patient with normal coronary arteries. Image quality of the whole-heart CMRA. The CMRA image quality of 62 patients is summarized in Table 2 . Ninety-three of 781 (12%) segments with a reference luminal diameter Ն1.5 mm on QCA were evaluated as nonassessable. The reasons for these segments were poor CNR (n ϭ 27), motion artifacts (n ϭ 39), and small CMRA failed to detect CAD in 2 patients (2 missed single-vessel disease, 1 in the first diagonal branch and 1 in the distal RCA). In 3 patients, CMRA detected CAD despite normal QCA (2 distal left circumflex coronary artery, 1 posterior descending artery, 1 distal left anterior descending coronary artery). Two patients who had no significant CAD on QCA were regarded as false positives because nonassessable segments were included for analysis.
Characteristics of the Study Population In a total of 688 assessable coronary segments, QCA detected a total of 91 lesions (Ն50%). CMRA correctly identified 83 of these lesions (sensitivity 91.2%). In 570 segments, stenosis was ruled out correctly by CMRA (specificity 95.5%). The main reasons for false positives were poor opacification and motion artifacts (89%). For the intention-to-diagnose analysis, the specificity decreased to 83.1% (570 of 686). A detailed overview of the diagnostic performance of 3.0-T CMRA compared with QCA is summarized in Table 3 . Figures 3 and 4 illustrate the detection of significant stenoses by CMRA with correlation to QCA. The kappa value for interobserver agreement for coronary artery stenosis detection with CMRA was 0.84.
Discussion
In this work, we have prospectively examined the diagnostic value of contrast-enhanced whole-heart CMRA at 3.0-T on patients suspected of CAD. Using an inversion recoveryprepared, navigator-gated spoiled gradient-echo sequence, CMRA was able to depict significant stenoses with overall sensitivity of 91.6%, 92.9%, and 94.1% based on persegment, -vessel, and -patient analyses, respectively. The negative predictive values were 98.6%, 96.9%, and 92.0%, respectively, indicating that the technique can reliably rule out significant stenoses, consistent with findings from previous studies (8, 9) . By including all false-positive nonassessable segments, the positive predictive values were lower (42.9%, 76.5%, 86.5%, respectively); however, they still Diagnostic Performance of 3.0-T Contrast-Enhanced Whole-Heart CMRA represent an improvement over a recent study using the SSFP technique at 1.5-T (14%, 38%, and 50%, respectively) (14) . The reduced incidents of false positives could be attributed to the potential benefits of contrast-enhanced data acquisition, which is T1-weighted, does not depend on blood inflow, and is less prone to signal loss due to complex flow as compared with SSFP data acquisition. Previous studies using whole-heart CMRA at 1.5-T have demonstrated promising clinical results, particularly for high negative predictive value. However, long scan time and relatively low spatial resolution have prevented its wide clinical acceptance as a routine test for coronary artery stenosis detection. The 3.0-T systems have the potential to improve SNR by a factor of 2 as compared with 1.5-T with the same imaging sequence.
Although SSFP has been the sequence of choice for CMRA at 1.5-T, there are substantial technical challenges of using SSFP imaging for CMRA at 3.0-T because of increased B 0 and B 1 field inhomogeneities and power deposition, despite various improvements in recent years (15) (16) (17) . Contrast-enhanced data acquisition overcomes many problems associated with SSFP and allows faster imaging because of its shorter TR. Reduced imaging time is critically important for whole-heart CMRA as long scan times tend to cause lower image quality from increased motion artifacts and reduced coronary SNR. The 3.0-T imaging and contrast-enhancement combined with inversionrecovery preparation allow high contrast between blood and background tissue. The depiction of distal coronary artery segments can be improved as a result. In this study, we were able to assess coronary artery segments with diameters Ͼ1.5 mm, as compared with 2.0 mm in previous 1.5-T studies (9) .
Multislice computed tomography emerged as a noninvasive method for imaging the coronary arteries several years ago. However, it has the disadvantages of requiring rapid injection of iodinated contrast medium and of exposing patients to ionizing radiation. In addition, blooming artifact from calcification leads to false positive diagnosis in many cases. A recent study by Liu et al. (18) demonstrated that CMRA has advantages over computed tomography angiography in the depiction of coronary lumen with severe calcification.
A major challenge for CMRA remains respirationinduced motion artifacts. Adaptive navigator-gating and motion correction is an effective method for reducing respiratory motion artifacts. However, the effectiveness of the method is related to the patient's breathing pattern. Patient training and practice before data acquisition for maintaining regular breathing should be useful to improve the gating efficiency and image quality of CMRA. Study limitations. Several important limitations exist in the current study. First, a fixed delay time of 60 s was applied between initiation of contrast agent infusion and start of imaging data acquisition. Such a setting may not necessarily be optimal for every patient owing to variations in physiological conditions (e.g., cardiac output, heart rate, blood pressure, respiratory gating efficiency) and contrast kinetics. Automatic triggering of data acquisition based on real-time tracking of signal enhancement (19) tailors such delay time to individual subjects and may potentially optimize signal enhancement for each patient. Second, com- 
